Angene Chemical
Draw
|
Currency :
Home Products

AG00IAWV

61718-82-9 | (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine

Chemical structure of (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine, CAS 61718-82-9
AG00IAWV
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 61718-82-9
Catalog Number AG00IAWV(AGN-PC-0T1FVG)
Chemical Name (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine
IUPAC Name (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
InChI InChI=1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14+;2-1-
InChI Key LFMYNZPAVPMEGP-PIDGMYBPSA-N
MDL Number MFCD00269809
Molecular Formula C19H25F3N2O6
Molecular Weight 434.4068
SMILES C(=C\C(O)=O)\C(O)=O.C(\CCCCOC)(=N\OCCN)/C1=CC=C(C(F)(F)F)C=C1
UNII 5LGN83G74V
Synonyms
Desiflu, DU 23000, DU-23000, DU23000, Dumirox, Faverin, Fevarin, Floxyfral, Fluvoxadura, Fluvoxamin AL, Fluvoxamin beta, Fluvoxamin neuraxpharm, Fluvoxamin ratiopharm, Fluvoxamin Stada, Fluvoxamin-neuraxpharm, Fluvoxamin-ratiopharm, Fluvoxamina Geminis, Fluvoxamine, Fluvoxamine Maleate, Fluvoxamine Maleate, (E)-Isomer, Fluvoxamine, (Z)-Isomer, Geminis, Fluvoxamina, Luvox, Novo Fluvoxamine, Novo-Fluvoxamine, Nu Fluvoxamine, Nu-Fluvoxamine, PMS Fluvoxamine, PMS-Fluvoxamine, ratio Fluvoxamine, ratio-Fluvoxamine, FLUVOXAMINE MALEATE, Luvox, 61718-82-9, Fevarin, Faverin, Floxyfral, Luvox CR, Fluvoxamine (maleate), UNII-5LGN83G74V, Dumirox, DU23000, DU-23000, SME 3110, 5LGN83G74V, 54739-18-3, Maveral, 5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate, 5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1), 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1), 54739-20-7, (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate, C19H25F3N2O6, MK-264, (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate, SMR000466268, SMR000653482, SR-01000075613, Fluvoxamine maleate [USAN], Depromel, MFCD00269809, Fluvoxamine maleate [USAN:USP], C15H21F3N2O2.C4H4O4, Luvox (TN), NSC 309469, (E)-Fluvoxamine Maleate, Fluvoxamine maleate, solid, CHEMBL1409, SCHEMBL35225, MLS000028469, MLS000758271, MLS001076285, MLS001304717, MLS001401391, CHEBI:5139, DTXSID3042558, HY-B0103A, HMS1571G11, HMS2098G11, HMS3261D11, HMS3676A13, HMS3715G11, Pharmakon1600-01505604, Fluvoxamine maleate (JP17/USAN), (2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine; but-2-enedioic acid, SME-3110, Tox21_500495, BG0368, NSC309469, NSC759602, s1336, AKOS015961142, AC-9541, CCG-213494, CS-1839, NSC-309469, NSC-759602, NCGC00093897-01, NCGC00093897-02, NCGC00261180-01, (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1), AN-39241, AS-11790, CPD000466268, SAM001246977, SMR000058449, AB2000054, AX8016087, LS-102000, TL8003932, EU-0100495, F0858, ST24035070, D00824, F 2802, J90043, 739F183, A833394, SR-01000075613-1, SR-01000075613-3, SR-01000075613-4, SR-01000075613-6, (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl)-1-pent, Fluvoxamine maleate, British Pharmacopoeia (BP) Reference Standard, Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard, Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard, (E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate, 5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime maleate, Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard, Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material, Fluvoxamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material, maleic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine, (Z)-2-butenedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine, (Z)-but-2-enedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine, (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine, 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime,(E)-, (Z)-2-butenedioate (1:1), 2-[({(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine (2Z)-but-2-enedioate, fluvoxamine, Fluroxamine, Fluvoxadura, Fluvoxamina, Fluvoxaminum, Desiflu, Fluvoxamin beta, Nu Fluvoxamine, Nu-Fluvoxamine, Fluvoxamin AL, Fluvoxamin Stada, Novo Fluvoxamine, Novo-Fluvoxamine, PMS Fluvoxamine, PMS-Fluvoxamine, ratio Fluvoxamine, ratio-Fluvoxamine, Fluvoxamina Geminis, Fluvoxamin ratiopharm, Fluvoxamin-ratiopharm, Geminis, Fluvoxamina, Fluvoxamin neuraxpharm, Fluvoxamin-neuraxpharm, Fluvoxamine [INN:BAN], Fluvoxamine, (Z)-Isomer, Fluvoxaminum [INN-Latin], D0M5JI, UNII-O4L1XPO44W, Fluvoxamina [INN-Spanish], Fluvoxamine Maleate, (E)-Isomer, C15H21F3N2O2, C15-H21-F3-N2-O2, CID9560989, DU 23000, C15-H21-F3-N2-O2.C4-H4-O4, D016666, (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate, (1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-aminoethyl)oxime, 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-, Fluvoxamine maleate, 98%, a selective serotonin (5-HT) reuptake inhibitor (SSRI) - 1G 1g, 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1),

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited